The DNA-damaging potential of tamoxifen in breast cancer and normal cells

Author： Wozniak Katarzyna   Kolacinska Agnieszka   Blasinska-Morawiec Maria   Morawiec-Bajda Alina   Morawiec Zbigniew   Zadrozny Marek   Blasiak Janusz  

Publisher： Springer Publishing Company

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.81, Iss.7, 2007-07, pp. : 519-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Camptothecin Resistance in Cancer: Insights into the Molecular Mechanisms of a DNA-Damaging Drug

By  

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1541-1565

Bentham Science Publishers

Access to resources Recommend Favorite

Eicosapentaenoic acid can restore tamoxifen sensitivity in resistant breast cancer cells

By  

Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents

By  

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 186-191

Bentham Science Publishers

Access to resources Recommend Favorite

Tamoxifen link to breast cancer confirmed

By  

Reactions Weekly, Vol. 1, Iss. 1269, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Human Mesenchymal Stem Cells (hMSCs) as Targets of DNA Damaging Agents in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 411-421

Bentham Science Publishers

Access to resources Recommend Favorite